April 19-20,2018Day one morning-Global Industry trends
Day one afternoon to Day two
Stream A -Drug Substance
Stream B --Formulation Design and development
Stream C-- Analytical Development and Support
Stream D-- Regulatory Planning and BE Studies Session
Lingmed helps pharmaceutical/device industry to improve productivities, make better decisions with intelligence databases. Currently Lingmed is the exclusive partner of EvaluatePharma and Biotechgate in China and GBI Source China’s local market partner. Lingmed databases cover more than 36,000 pharma, medtech and biotech companies, over 45,000 innovative products’ active licensing opportunities. Lingmed databases are the trusted source for life science market intelligence and analysis with exclusive consensus forecasts, which supports life science and healthcare companies in their strategic decision-making. Lingmed also supports oversea innovative assets to enter China market on deal making with local BD professionals.